Bronchoalveolar lavage enzyme-linked immunospot for diagnosis of smear-negative tuberculosis in HIV-infected patients.
Bronchoalveolar lavage enzyme-linked immunospot for diagnosis of smear-negative tuberculosis in HIV-infected patients.
复制标题
DOI:
10.1371/journal.pone.0039838
复制
发表时间:
2012
期刊:
影响因子:
3.7
通讯作者:
Huang L
中科院分区:
文献类型:
--
作者:
Cattamanchi A;Ssewenyana I;Nabatanzi R;Miller CR;Den Boon S;Davis JL;Andama A;Worodria W;Yoo SD;Cao H;Huang L
Peripheral blood interferon-gamma release assays (IGRAs) have sub-optimal sensitivity and specificity for diagnosis of active pulmonary tuberculosis (TB). However, assessment of local immune responses has been reported to improve the accuracy of TB diagnosis. We enrolled HIV-infected adults with cough ≥2 weeks’ duration admitted to Mulago Hospital in Kampala, Uganda and referred for bronchoscopy following two negative sputum acid-fast bacillus smears. We performed an ELISPOT-based IGRA (T-SPOT.TB®, Oxford Immunotec, Oxford, UK) using peripheral blood and bronchoalveolar lavage (BAL) fluid mononuclear cells, and determined the accuracy of IGRAs using mycobacterial culture results as a reference standard. 94 HIV-infected patients with paired peripheral blood and BAL IGRA results were included. The study population was young (median age 34 years [IQR 28–40 years]) and had advanced HIV/AIDS (median CD4+ T-lymphocyte count 60 cells/µl [IQR 22–200 cells/µl]). The proportion of indeterminate IGRA results was higher in BAL fluid than in peripheral blood specimens (34% vs. 14%, difference 20%, 95% CI 7–33%, p = 0.002). BAL IGRA had moderate sensitivity (73%, 95% CI 50–89%) but poor specificity (48%, 95% CI 32–64%) for TB diagnosis. Sensitivity was similar (75%, 95% CI 57–89%) and specificity was higher (78%, 95% CI 63–88%) when IGRA was performed on peripheral blood. BAL IGRA performed poorly for the diagnosis of smear-negative TB in a high HIV/TB burden setting. Further studies are needed to examine reasons for the large proportion of indeterminate results and low specificity of BAL IGRA for active TB in high HIV/TB burden settings.
登录
查看更多内容
影响因子:
4.4
作者:
Caccamo, Nadia;Meraviglia, Serena;Salerno, Alfredo
通讯作者:
Salerno, Alfredo
影响因子:
3.8
作者:
Clerici, M;Butto, S;Lopalco, L
通讯作者:
Lopalco, L
DOI:
10.1164/rccm.200904-0557oc
发表时间:
2009-10-01
影响因子:
24.7
作者:
Jafari, Claudia;Thijsen, Steven;Lange, Christoph
通讯作者:
Lange, Christoph
影响因子:
11.1
作者:
Jafari, C.;Kessler, P.;Lange, C.
通讯作者:
Lange, C.
DOI:
10.14745/ccdr.v36i00a05
发表时间:
2010-06-01
期刊:
Canada communicable disease report = Releve des maladies transmissibles au Canada
影响因子:
--
作者:
Kunimoto, Dennis;Gardam, Drs Michael;Wobeser, Wendy
通讯作者:
Wobeser, Wendy